Atlas Trials

Type 1 Gaucher Disease

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Type 1 Gaucher Disease

RecordFirmDate
A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02 (NCT04836377)AVROBIO2021-07-06
Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease (NCT03021941)Pfizer2019-07-31
A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients (NCT00813865)Amicus Therapeutics2009-05-11
A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 (NCT00875160)Amicus Therapeutics2009-04-01
A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease (NCT00446550)Amicus Therapeutics2008-06-11
A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy (NCT00433147)Amicus Therapeutics2007-03-23

Track Type 1 Gaucher Disease automatically

Every clearance here is in the API, with alerts when new ones post.